Brian Dahl

Brian Dahl

Brian Dahl is the senior director and practice lead for corporate compliance and ethics at ProPharma Group.

Recent posts

Corporate Compliance Programs: The Importance of Being Effective
Now more than ever, pharmaceutical companies must not only have an effective Corporate Compliance Program in place, but senior management and boards of directors at these companies must ensure that their... Read more »

Page 1 of 1

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX

Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX

Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.

From Our Advertisers

Investment in Wisconsin startups reaches new record total
Tax credits help tech innovators attract capital, fuel growth
Wisconsin Economic Development Corporation

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

IDG Tech Network

Protected by Carbonite

Eventbrite - events made easy